How does this therapy differ from biologic injections?

This medicine is a selective TYK2 inhibitor taken as a tablet. By targeting intracellular signaling, it modulates pathways linked to plaque formation. Biologic injections act on targets outside cells, such as IL‑17 or IL‑23, and are given by subcutaneous injection or infusion. Sotyktu appears in a different class and offers an oral route. Each option carries unique benefits and risks. The care team will choose based on disease severity, comorbidities, past response, and patient preference.

Can it be taken with food, alcohol, or coffee?

The tablet may be taken with or without food according to the label. Moderate alcohol use is not specifically contraindicated but can aggravate skin or interact with other medicines, so clinicians often advise caution. Caffeine does not have a known direct interaction with deucravacitinib. Specific dietary limits can depend on other conditions and treatments. When uncertain, follow the official label and the prescriber’s guidance.

Are tests needed before starting treatment?

Prescribers commonly screen for latent tuberculosis before initiation, and review infection history. Depending on the clinical picture, hepatitis screening or other baseline labs may be considered. Vaccination status is often reviewed, with live vaccines avoided during treatment. Ongoing monitoring is tailored to risk factors and symptoms rather than a fixed universal schedule. Follow the plan set by the treating clinician and the product labeling.

What should patients know about vaccines while on therapy?

Live vaccines are generally avoided during treatment and for a period after, per label guidance. Inactivated and mRNA vaccines may be considered, but timing can be adjusted to maximize response. Plans depend on disease activity, exposure risk, and community outbreaks. Discuss specific vaccines, including zoster and influenza, with the care team before administration.

Is it safe during pregnancy or breastfeeding?

There is limited human experience in pregnancy and lactation. Animal data cannot reliably predict outcomes in people. Clinicians usually weigh severity of psoriasis against potential risks and consider alternative therapies when planning conception, pregnancy, or nursing. If exposure occurs, the prescriber may discuss options and monitoring. Decisions should align with the official label and specialist advice.

How long before improvement is noticeable?

Responses vary widely. Some patients observe gradual changes in plaque thickness and scaling over time, while others require treatment adjustments. Because psoriasis fluctuates, it can take steady daily dosing and regular follow-up to understand the pattern of response. Clinicians may review skin scores and quality-of-life measures to guide next steps. No specific timeframe can be promised.

Can patients switch from another psoriasis therapy to this one?

Switching strategies depend on the prior medicine and current disease control. A clinician may use washout periods, overlap, or direct switches based on risk and the therapies involved. Live vaccine status, infection screening, and lab history are considered before changes. Never start or stop systemic psoriasis treatments without guidance from a qualified prescriber.

Promotion

Sotyktu

Sotyktu® Tablets for Plaque Psoriasis

Plaque Psoriasis

Please note: a valid prescription is required for all prescription medication.

Stock up and Save - Get 20% off when you buy 3 or more of any one product. Use code SAVE20 at checkout.

Coupon code cannot be combined with other offers. Sale applies to all products originating from Canada. Maximum allowable quantity equal to a 90 day supply per single order.

Price:

Price range: $4,717.99 through $4,929.99

Secure Encrypted Payments

What Sotyktu Is and How It Works

Sotyktu® is an oral TYK2 inhibitor for adults with plaque psoriasis. This page explains options, including Sotyktu without insurance, with US shipping from Canada. It helps compare access, dosing basics, and safety topics in one place.

YouDrugstore is a licensed Canadian pharmacy in Manitoba. Pharmacists review prescriptions before dispensing.

The treatment contains deucravacitinib, a selective TYK2 inhibitor. TYK2 sits inside immune cells and helps transmit signals from cytokines that drive plaque formation. By modulating that pathway, this medicine can reduce inflammatory activity in skin. It is taken by mouth, which may suit people who prefer tablets over injections or light therapy. For an overview of the condition, see Plaque Psoriasis in our condition library.

Who It’s For

This therapy is indicated for adults with moderate to severe plaque psoriasis who are candidates for systemic treatment or phototherapy. It is not approved for children. People with active serious infections should not start until those are controlled. A prescriber may screen for tuberculosis before treatment and may consider hepatitis history.

Discuss use in pregnancy or while nursing with a healthcare professional. Those with a history of malignancy, frequent infections, or immunosuppression need careful evaluation. Avoid live vaccines during and shortly after therapy as directed by the official label.

Dosage and Usage

Label-directed Sotyktu dosing is once daily. Take the tablet about the same time each day. It may be taken with or without food. Swallow the tablet whole with water. Do not split, crush, or chew unless a prescriber has provided specific instructions consistent with the official label.

If other medicines are prescribed for psoriasis or other conditions, the prescriber will decide whether to continue, stop, or stagger them. Do not start or stop therapies without medical guidance. When uncertain, follow the Product Monograph or FDA Prescribing Information.

Strengths and Forms

Commonly supplied as film-coated Sotyktu tablets 6 mg. Packaging and counts can vary by manufacturer and market. The generic ingredient is deucravacitinib. Availability of certain pack sizes can differ between pharmacies. Check the product listing for currently stocked presentations.

Missed Dose and Timing

If a dose is missed, take it when remembered unless it is close to the next scheduled dose. If it is nearly time for the next dose, skip the missed one and resume the regular schedule. Do not take two doses at once. Consistent daily timing may help with routine and adherence, which supports steady exposure.

Storage and Travel Basics

Store tablets at standard room conditions as directed by the manufacturer. Keep in the original bottle with the label intact. Protect from moisture and keep the cap closed tightly. Keep out of reach of children and pets.

For travel, carry the prescription-labeled container in a cabin bag. A copy of the prescription and a medication list can ease security checks. Use a pill organizer only if it will not expose tablets to humidity. If crossing borders, keep documents handy and allow extra time for inspection.

Benefits

This medicine gives an oral, once-daily option for systemic management of plaque psoriasis. Many appreciate tablet convenience compared with clinic-based phototherapy or injections. As a selective TYK2 inhibitor, the treatment targets pathways involved in skin inflammation. Results and tolerability vary. The care team will decide whether this option fits the overall plan.

Side Effects and Safety

Review of Sotyktu side effects helps set expectations. Many effects are mild to moderate and resolve with time or supportive care. Not everyone experiences these effects.

Upper respiratory tract symptoms
Headache or fatigue
Nausea or diarrhea
Acne or skin irritation
Cold sores or oral discomfort

Serious risks can include severe infections, shingles, or rare malignancies. People with latent tuberculosis may reactivate without proper management. Seek urgent care for signs of serious infection, shortness of breath, chest pain, severe abdominal pain, or new neurological symptoms. The prescriber may monitor for infections and other safety signals per the label.

Drug Interactions and Cautions

Tell the prescriber about all medicines, vitamins, and herbal supplements. Combining with other potent immunosuppressants can raise infection risk. Live vaccines should be avoided during treatment. Discuss recent vaccinations and timing for any needed immunizations.

Some strong enzyme inhibitors or inducers may affect drug levels. The prescriber will decide if adjustments or alternatives are needed. Liver or kidney concerns require clinical review. For more on biologic therapies and how they differ, see Enbrel Injection Uses and our Dermatology category.

What to Expect Over Time

Clinical responses can build gradually. Skin plaques may soften, shrink, or become less scaly as inflammation settles. Some days will be better than others. Keep consistent daily dosing unless the prescriber advises a change. Regular follow-up helps track progress, review tolerability, and adjust plans if needed.

Maintaining sleep, gentle skin care, and trigger awareness can support therapy. Educational resources such as World Psoriasis Day and Psoriasis Action Month may offer community tips.

Compare With Alternatives

Two approved options we stock may be discussed with a prescriber:

Otezla®: an oral PDE4 inhibitor for plaque psoriasis and psoriatic arthritis.
Taltz: an injectable IL-17A inhibitor used in moderate to severe disease.

These medicines work differently and have distinct safety profiles. The care plan may consider prior treatments, comorbid conditions, and preferences. See our Plaque Psoriasis page for broader therapy pathways.

Pricing and Access

Explore Canadian options with US delivery from Canada and compare access pathways. Some patients look for cash-pay choices through online pharmacies when coverage is limited. Our encrypted checkout supports secure payment.

Review Sotyktu price on the product page, then sign in to see current availability. For additional ways to save, check our Promotions. Always follow the prescriber’s directions; this page does not replace clinical advice.

Availability and Substitutions

Stock can vary. If the requested pack is unavailable, a prescriber may recommend an alternative strength or therapy from the same class. Some markets describe the active as Deucravacitinib 6 mg. When exact presentations are not listed, contact our team so we can coordinate with the prescriber about options that meet the same clinical intent.

Patient Suitability and Cost-Saving Tips

Good candidates are adults with moderate to severe plaque psoriasis who need a systemic option and are appropriate for a TYK2 inhibitor. Those with uncontrolled infections or recent live vaccines are typically not candidates until cleared. Discuss cancer history, chronic infections, or planned surgeries with a healthcare professional before starting.

Cost-conscious strategies can include multi-month fills when approved by the prescriber, which can reduce per-tablet dispensing fees. Setting refill reminders in your account helps avoid treatment gaps. Consolidating orders may minimize separate transaction fees. Keep a shared medication list to prevent duplicate therapies across clinics.

Questions to Ask Your Clinician

Is a TYK2 inhibitor appropriate given disease severity and past treatments?
How will infection risk be monitored during therapy?
What vaccinations should be updated before starting?
Which medicines, supplements, or herbs could interact?
What is the plan if plaques do not respond as expected?
Are there recommended skin care routines to support therapy?

Authoritative Sources

FDA Prescribing Information

Manufacturer Product Page

Health Canada Drug Product Database

Ready to proceed? Place your order with prompt, express US delivery from Canada, with temperature-controlled handling when required. This information is educational and does not replace advice from a healthcare professional.

Express Shipping - from $25.00

Shipping with this method takes 3-5 days

Prices:

Dry-Packed Products $25.00
Cold-Packed Products $35.00

Shipping Countries:

United States (all contiguous states**)
Worldwide (excludes some countries***)

Standard Shipping - $15.00

Shipping with this method takes 5-10 days

Prices:

Dry-Packed Products $15.00
Not available for Cold-Packed products

Shipping Countries:

United States (all contiguous states**)
Worldwide (excludes some countries***)

View All FAQs

How does this therapy differ from biologic injections?
This medicine is a selective TYK2 inhibitor taken as a tablet. By targeting intracellular signaling, it modulates pathways linked to plaque formation. Biologic injections act on targets outside cells, such as IL‑17 or IL‑23, and are given by subcutaneous injection or infusion. Sotyktu appears in a different class and offers an oral route. Each option carries unique benefits and risks. The care team will choose based on disease severity, comorbidities, past response, and patient preference.
Can it be taken with food, alcohol, or coffee?
The tablet may be taken with or without food according to the label. Moderate alcohol use is not specifically contraindicated but can aggravate skin or interact with other medicines, so clinicians often advise caution. Caffeine does not have a known direct interaction with deucravacitinib. Specific dietary limits can depend on other conditions and treatments. When uncertain, follow the official label and the prescriber’s guidance.
Are tests needed before starting treatment?
Prescribers commonly screen for latent tuberculosis before initiation, and review infection history. Depending on the clinical picture, hepatitis screening or other baseline labs may be considered. Vaccination status is often reviewed, with live vaccines avoided during treatment. Ongoing monitoring is tailored to risk factors and symptoms rather than a fixed universal schedule. Follow the plan set by the treating clinician and the product labeling.
What should patients know about vaccines while on therapy?
Live vaccines are generally avoided during treatment and for a period after, per label guidance. Inactivated and mRNA vaccines may be considered, but timing can be adjusted to maximize response. Plans depend on disease activity, exposure risk, and community outbreaks. Discuss specific vaccines, including zoster and influenza, with the care team before administration.
Is it safe during pregnancy or breastfeeding?
There is limited human experience in pregnancy and lactation. Animal data cannot reliably predict outcomes in people. Clinicians usually weigh severity of psoriasis against potential risks and consider alternative therapies when planning conception, pregnancy, or nursing. If exposure occurs, the prescriber may discuss options and monitoring. Decisions should align with the official label and specialist advice.
How long before improvement is noticeable?
Responses vary widely. Some patients observe gradual changes in plaque thickness and scaling over time, while others require treatment adjustments. Because psoriasis fluctuates, it can take steady daily dosing and regular follow-up to understand the pattern of response. Clinicians may review skin scores and quality-of-life measures to guide next steps. No specific timeframe can be promised.
Can patients switch from another psoriasis therapy to this one?
Switching strategies depend on the prior medicine and current disease control. A clinician may use washout periods, overlap, or direct switches based on risk and the therapies involved. Live vaccine status, infection screening, and lab history are considered before changes. Never start or stop systemic psoriasis treatments without guidance from a qualified prescriber.